# Moderate Alcohol Intake Among Patients With Type 2 Diabetes

Study · id `cardio:ct-nct00295334` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00295334](<https://clinicaltrials.gov/study/NCT00295334>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00295334

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.

## Technical summary

Registry record NCT00295334. Randomized; single masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2025-06-24.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 109 participants (enrolled count; ClinicalTrials.gov record NCT00295334, source copy `cardio:ctgov-nct00295334-2025-06-24`, retrieved 2026-10-26)
- Start date: 2010-06 (registry gives no type) (ClinicalTrials.gov record NCT00295334, source copy `cardio:ctgov-nct00295334-2025-06-24`, retrieved 2026-10-26)
- Primary completion: 2012-05 (actual) (ClinicalTrials.gov record NCT00295334, source copy `cardio:ctgov-nct00295334-2025-06-24`, retrieved 2026-10-26)
- Completion: 2012-05 (actual) (ClinicalTrials.gov record NCT00295334, source copy `cardio:ctgov-nct00295334-2025-06-24`, retrieved 2026-10-26)
- Results first posted: 2025-06-24 (ClinicalTrials.gov record NCT00295334, source copy `cardio:ctgov-nct00295334-2025-06-24`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00295334-2025-06-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Moderate Alcohol Intake Among Patients With Type 2 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Drug): alcohol
- Lead sponsor: Iris Shai
- Lead sponsor class: OTHER
- Collaborator: The Israeli Diabetes Research Group
- Collaborator class: UNKNOWN
- Collaborator: Hadassah Medical Organization
- Collaborator class: OTHER
- Collaborator: Soroka University Medical Center
- Collaborator class: OTHER
- Collaborator: Julio Vainstein, Wolfson Medical Center, Holon, Israel
- Collaborator class: UNKNOWN
- Collaborator: Tishbi Wines, Israel and Admiral Wine Imports, US
- Collaborator class: UNKNOWN
- Collaborator: Harvard University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Hadassah Medical Organization (`cardio:org-hadassah-medical-organization`)

## Provenance

Content hash: 4fd350862489b16b906105c4296c7f0a7b24ab155cd533c41c460ea3f9171a37
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
